- Type Lifetime
- Verdict Skip
- Status Active
- Updated Jul 10, 2026
- Confidence Medium
- Score 3/10
Verdict: Skip
Equitest's $99 lifetime price is attractive, but documented accuracy complaints, a Xero import bug, and an undisclosed methodology make it a high-risk purchase. An inaccurate valuation tool offers no ROI, so test the free trial hard before committing.
Equitest deal: quick verdict
Skip 3/10- Verdict
- Skip (3/10)
- Price
- $99 one-time (normally $99/mo)
- Best for
- Startup founders preparing seed or pre-seed fundraising rounds
- Skip if
- General small business owners who want a realistic market price should consider ValuAdder, since Equitest's VC-oriented methods draw repeated unrealistic-valuation complaints.
- Bottom line
- Equitest's $99 lifetime price is attractive, but documented accuracy complaints, a Xero import bug, and an undisclosed methodology make it a high-risk purchase. An inaccurate valuation tool offers no ROI, so test the free trial hard before committing.
Last verified Jul 10, 2026 by Alston Antony.
How we calculated this deal's 60/100 score
Every deal gets a score out of 100 built from five weighted factors, computed from the same research used to write this review. No factor is guessed: when data for a factor isn't available (for example, an older deal published before we started tracking vendor trust signals), that factor falls back to a neutral, non-penalizing score instead of being invented.
| Category | Points | What it measures |
|---|---|---|
| Verdict Strength | 12/40 | Based on our 1-10 editorial verdict score from hands-on research (or the BUY/WAIT/SKIP call itself when no numeric score was recorded). |
| Deal Value | 24/25 | How steep the confirmed discount is versus the regular price, when that price is available. |
| Feature Completeness | 8/15 | How the tool holds up against named competitors on the feature comparison table. |
| Vendor Trust | 9/10 | The vendor's domain authority, safety record, and how long the company has been operating. |
| Deal Terms & Risk | 7/10 | Refund window length, code-stacking policy, and how confident our research was overall. |
On this page9 sections
Get This Deal → Affiliate link - see our disclosure.
Equitest deal terms
- Refund window
- 60-day money-back guarantee
What is Equitest?
Equitest is an AI business valuation platform that generates 30+ page reports using DCF, VC Method, and multiples in about 20 minutes. The Equitest lifetime deal is $99 one-time on AppSumo (base tier, 16 valuations for life), replacing a $99/month subscription, backed by a money-back guarantee window you must confirm on the deal page.
The Equitest lifetime deal sells for $99 one-time on AppSumo, replacing a $99/month subscription that would otherwise reach about $1,188 per year, so the math breaks even in roughly twelve months. Equitest is an AI business valuation platform that produces 30+ page reports using DCF, the VC Method, and multiples in around twenty minutes. The catch shows up early: multiple AppSumo reviewers report that the valuations come back unrealistic, with one user saying the numbers were on another planet when back-tested against real negotiations, and a separate Xero import bug pulls incorrect balance sheet figures that you must fix by hand. If accurate, auditable numbers matter more than speed, Equidam is the stronger choice because it publishes its full valuation methodology and supports 90+ countries, while ValuAdder offers a one-time license with offline operation and 15+ methods. The lifetime price is genuinely low, but a valuation tool is only worth buying if you trust its output, and the documented accuracy complaints are the central reason to test this one carefully on the free trial before paying.
Pros & Cons
Pros
- At $99 one-time, the lifetime deal undercuts the $99/month subscription and breaks even in about twelve months, a real saving for advisors who value companies regularly.
- Equitest generates a full 30+ page professional report in roughly twenty minutes, covering six valuation methods including DCF and the VC Method, which speeds up first-pass work.
- The platform bundles extras beyond raw valuation, including cap table management, risk analysis, and pitch deck plus investment proposal letter generation.
- The CEO is documented on AppSumo as actively supporting buyers with detailed explanation sessions, a stronger signal than many silent lifetime deal sellers.
- A 7-day free trial lets you run unlimited valuations before buying, so you can test accuracy against known numbers before spending anything.
Cons
- The most serious con is documented accuracy: several AppSumo reviewers call the valuations unrealistic and gimmicky, and that review remains visible and seemingly unresolved.
- The Xero integration has been reported to import incorrect balance sheet numbers, undercutting the automation benefit and forcing manual correction every time.
- The valuation methodology is not fully published, so you cannot audit how inputs become outputs, unlike Equidam's transparent methodology document.
- Sparse public review volume, acknowledged by the Equitest team itself, makes it harder to gauge real-world reliability before purchase.
- The 16 valuations for life base tier is ambiguous, and it is unclear whether lifetime updates include new methods or only bug fixes.
What It Does
- Generates 30+ page professional valuation reports automatically
- Runs DCF, VC Method, and multiples valuations
- Integrates real-time market data into assessments
- Manages cap tables and basic risk analysis
- Creates pitch decks and investment proposal letters
- Imports financials from Xero for faster setup
Who It's For
- Startup founders preparing seed or pre-seed fundraising rounds
- CPAs and accountants offering valuation services to clients
- M&A advisors and business brokers needing fast first-pass reports
Pricing Comparison
| Plan | Price | Type |
|---|---|---|
| Equitest Lifetime Deal (base) | $99 one-time | ⭐ Best Value |
| Equitest Monthly Plan | $99/month | Subscription |
| BizEquity | Check pricing > | Subscription / Advisor |
| Equidam | Check pricing > | Subscription |
| ValuAdder | One-time license | Lifetime License |
Feature Comparison
| Feature | Equitest | Equidam | ValuAdder |
|---|---|---|---|
| AI-generated 30+ page report | ✅ | ✅ | ❌ |
| Number of valuation methods | ✅ (6 methods) | ✅ | ✅ (15+ methods) |
| One-time lifetime price | ✅ ($99 LTD) | ❌ | ✅ |
| Published, transparent methodology | ❌ | ✅ | ✅ |
| Offline operation, no account required | ❌ | ❌ | ✅ |
| Global coverage (90+ countries) | ❌ | ✅ | ❌ |
| Investor-ready instant share report | ❌ | ✅ | ❌ |
| Export to Excel for analysis | ❓ | ❓ | ✅ |
| Xero financial data import | ✅ (with reported bugs) | ❓ | ❌ |
| Cap table management | ✅ | ❓ | ❌ |
Limitations
- Multiple AppSumo reviewers report that Equitest valuations come back unrealistic and gimmicky, with one professional stating results were on another planet when back-tested against actual negotiations and the Syft tool.
- The Xero financial data import has been reported on AppSumo to pull incorrect balance sheet numbers, forcing users to manually verify and correct figures after import, which erodes the time-savings promise.
- The Equitest team has acknowledged on AppSumo that they have not actively encouraged customers to leave reviews, so the public review volume is sparse and harder for new buyers to assess.
- Coverage is niche: zplatform.ai research notes the tool suits startup founders, CPAs, and M&A advisors but is a poor fit for general small business owners seeking realistic market value.
- The valuation methodology is not fully published, unlike Equidam which releases a detailed methodology PDF, so inputs and calculations function as a black box you cannot fully audit.
- The integration ecosystem is thin: beyond Xero, independent listings do not document QuickBooks, Stripe, or PayPal connections that competing finance SaaS tools typically offer.
- Per softwaresuggest.com and AppSumo feedback, the base offering can feel pricey for startups on a tight budget, and the meaning of 16 valuations for life is not clearly defined in the deal terms.
- It is unclear from the deal terms whether lifetime updates include new AI valuation methods or only bug fixes, a narrower lifetime promise than ValuAdder's full license updates.
What's Missing vs Competitors
- BizEquity provides a four-value breakdown across asset sale, equity, enterprise, and liquidity values in its reports, a structured output Equitest does not document.
- Equidam publishes a full transparent valuation methodology and supports 90+ countries and 641+ industries, neither of which Equitest matches.
- ValuAdder offers full offline operation with no logins, servers, or accounts plus 15+ valuation methods, while Equitest requires internet access and ships 6 methods.
- Equidam auto-gathers public company data and drafts projections in about 10 minutes, faster than Equitest's roughly 20-minute generation time.
Who Should Skip This Deal
- General small business owners who want a realistic market price should consider ValuAdder, since Equitest's VC-oriented methods draw repeated unrealistic-valuation complaints.
- Advisors who need transparent, auditable calculations should choose Equidam, which publishes its full methodology while Equitest keeps its model a black box.
- Buyers who want offline software with permanent data privacy should pick ValuAdder, which runs on Mac or Windows with no account or server dependency.
- Global users valuing companies across many countries should use Equidam for its 90+ country and 641+ industry coverage that Equitest lacks.
Equitest in action
Equitest vendor check
- Domain Rating
- 78/100 Backlink authority
- In business since
- 2009
- Monthly visitors
- ~102K Est. organic
- Ranks for
- 21,711 keywords Organic search
- Traffic value
- ~$72K/mo Equivalent ad spend
- Security
- No known flags Google Safe Browsing
Domain Rating & traffic data by Ahrefs. Objective third-party data, not our opinion.
Lifetime Deal Savings Calculator
Work out whether a lifetime deal actually beats the subscription. Enter the monthly price of the tool you would replace and the one-time lifetime price. The single most important number is the break-even: how fast you recover the cost. Recovering it quickly is what protects you if the company shuts down later.
This lifetime deal pays for itself in 1 months and saves $5,841 over 5 years versus paying monthly.
Roughly 1 in 10 lifetime deal companies shut down within five years. Recovering your cost fast, and buying only tools you will use right away, is how you stay ahead of that risk. This is an estimate, not financial advice.
How Equitest's price compares
Equitest is the 14th-cheapest of 15AI Analyticslifetime deals we've reviewed. At $99 it is above the $69 median for AI Analytics lifetime deals we've reviewed. It ranks 15th by verdict score (3/10) among the same group.
Frequently Asked Questions
- At $99 one-time versus $99 per month, the lifetime deal pays for itself in about twelve months, so the price is genuinely low for anyone who runs valuations regularly. The problem is value, not cost. Multiple AppSumo reviewers report that Equitest valuations come back unrealistic, with one professional saying the figures were far off when back-tested against real negotiations and a competing tool. A valuation tool is only worth buying if you trust its output, so the honest answer is conditional: it can be worth it for fast first-pass reports if you independently verify the numbers, but it is not a set-and-forget valuation source. Use the free 7-day trial first and test it against valuations you already know to be correct.
- Equitest is sold through AppSumo, and sources mention a money-back guarantee in the 30 to 60 day range, with softwaresuggest.com citing a 60-day window. AppSumo's standard marketplace refund terms generally allow a 60-day money-back guarantee, but per-deal terms vary and some digital products carry exceptions, so you must read the Deal Terms section on the AppSumo listing before purchasing. Given the documented accuracy complaints, the refund window is your main safety net, so confirm the exact number of days and any conditions at checkout. Treat the trial period plus the refund window as one continuous testing runway: validate the tool against known valuations early so you still have time to request a refund if the numbers do not hold up.
- Equidam and Equitest both produce investor-oriented valuation reports, but they differ in transparency, speed, and coverage. Equidam publishes a full valuation methodology document, auto-gathers public company data, drafts projections in about ten minutes, and supports 90+ countries and 641+ industries. Equitest takes roughly twenty minutes, keeps its methodology largely undisclosed, and documents a narrower integration and coverage footprint. Where Equitest wins is price: it offers a $99 one-time lifetime deal, while Equidam runs on a subscription with no lifetime option found in research. If auditable, transparent numbers and global coverage matter most, Equidam is the safer pick. If you want a low one-time cost and are willing to verify outputs yourself, Equitest is the cheaper entry point.
- The biggest limitation is valuation accuracy: several AppSumo reviewers describe the results as unrealistic and significantly different from actual negotiations and other tools. Second, the Xero financial data import has been reported to bring in incorrect balance sheet numbers that require manual correction. Third, the methodology is a black box, since Equitest does not publish detailed calculation inputs the way Equidam does. Fourth, public review volume is thin, which the Equitest team has openly acknowledged. Additional limitations include a niche use case aimed at founders, CPAs, and M&A advisors rather than general business owners, a thin integration ecosystem beyond Xero, and ambiguous lifetime deal terms around the 16 valuations cap and whether updates include new valuation methods.
- General small business owners who need a realistic sale price should not buy Equitest, because its VC-oriented methods draw repeated unrealistic-valuation complaints; ValuAdder, with its one-time license and 15+ methods, is a better fit. Advisors who need transparent, auditable calculations should skip it in favor of Equidam, which publishes its full methodology. Buyers who want offline software with permanent data privacy should choose ValuAdder, which runs locally on Mac or Windows with no account required. Finally, anyone valuing companies across many countries should use Equidam for its 90+ country and 641+ industry coverage. In short, skip Equitest if accuracy, transparency, offline control, or global reach outrank a low one-time price.
Is Equitest worth the money?
What is the refund policy for Equitest?
How does Equitest compare to Equidam?
What are the main limitations of Equitest?
Who should NOT buy Equitest?
Sources
Related tools & guides
Alternatives to Equitest
Other active deals in AI Analytics
Deals That Pair Well With Equitest
Pairs well with AI SEO and AI Marketing and AI Automation and AI Research tools
Comments
Loading comments...